Which type of medication is indicated for acute bronchospasm relief?

Short-acting beta-agonists are specifically designed for the rapid relief of acute bronchospasm. They work by stimulating beta-2 adrenergic receptors in the airways, leading to bronchial smooth muscle relaxation and dilation. This action quickly alleviates symptoms such as wheezing, shortness of breath, and chest tightness, making them the first-line treatment for sudden asthma attacks or other forms of bronchospasm that may occur in conditions like Chronic Obstructive Pulmonary Disease (COPD) and asthma.

In contrast, long-acting beta-agonists are intended for maintenance treatment and are not suitable for acute relief due to their slower onset of action. Leukotriene receptor antagonists and mast cell stabilizers work through different mechanisms, focusing on reducing inflammation and preventing bronchoconstriction rather than directly providing immediate bronchodilation. Therefore, in a situation requiring quick relief from bronchospasm, short-acting beta-agonists are the appropriate choice.